BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 79.50
-1.50 (-1.85%)
At close: Mar 27, 2026
BIONET Market Cap
BIONET has a market cap or net worth of 4 billion as of March 27, 2026. Its market cap has decreased by -5.46% in one year.
Market Cap
4.00B
Enterprise Value
3.70B
Revenue
1.24B
Ranking
n/a
PE Ratio
77.94
Stock Price
79.50
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 4.00B, an increase of 249.73%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 4.00B | -23.19% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 237.54B |
| Caliway Biopharmaceuticals | 126.10B |
| Heron Neutron Medical | 61.90B |
| Bora Pharmaceuticals | 57.78B |
| BioGend Therapeutics | 4.22B |
| Bonraybio | 4.12B |
| ACRO Biomedical | 4.08B |
| Orient EuroPharma | 4.00B |